Navigation Links
BD to Present at the Deutsche Bank 38th Annual Health Care Conference
Date:5/24/2013

FRANKLIN LAKES, N.J., May 24, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Deutsche Bank 38th Annual Health Care Conference on Thursday, May 30, 2013, at 10:40 a.m. (ET).

A live webcast of BD's presentation can be accessed from the BD corporate website at www.bd.com/investors and will be available for replay through Thursday, June 6, 2013.   

About BD
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents.  The Company is dedicated to improving people's health throughout the world.  BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines.  BD's capabilities are instrumental in combating many of the world's most pressing diseases.  Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 30,000 associates in more than 50 countries throughout the world.  The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.  For more information, please visit www.bd.com.

Contact:
Monique N. Dolecki , Investor Relations – 201-847-5378
Colleen T. White , Corporate Communications – 201-847-5369


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma
2. Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference
3. Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference
4. Neurocrine Biosciences to Present At The Deutsche Bank 38th Annual dbAccess Health Care Conference
5. Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference
6. Haemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conference
7. CASMED to Present at the 2nd Annual Marcum MicroCap Conference
8. Intercept Pharmaceuticals to Present at Deutsche Bank Healthcare Conference
9. Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference
10. Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML)
11. BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... As health officials across the Midwest warn against the ... Michigan will offer free diagnostic testing ... pharmacists to administer tests and, in some cases, fill the ... in the study. The Grand Rapids, ...
(Date:1/15/2014)... OAKS, Calif. , Jan. 15, 2014 ... Amgen (NASDAQ: AMGN ) announced today ... jointly discover and validate new therapeutic targets and ... a chronic disorder that affects millions worldwide. The ...
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
Breaking Medicine Technology:Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 2Meijer Pharmacy Offers Free Flu, Strep Testing as Influenza Cases Rise Across the Midwest 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Intellectual Property Insurance for Medical-related Products and Services 2
... 2011 /PRNewswire-iReach/ --  Janet R. Dees, CEO/President of ... opening of its newest vascular access center in Columbus, ... success for American Vascular Access, LLC., and the addition ... R. Dees, CEO/President.   "Our goal has continued ...
... Holdings, Inc. (NYSE: ZMH ; SIX: ZMH), a ... of its CLS® Brevius ™ Hip Stem with ... new technology enables surgeons to better match patients, individual ... adjustments. "Following its introduction in Europe earlier ...
Cached Medicine Technology:American Vascular Access Continues Growth in Georgia 2Zimmer Introduces New CLS® Brevius™ Hip Stem with Kinectiv® Technology in the United States 2Zimmer Introduces New CLS® Brevius™ Hip Stem with Kinectiv® Technology in the United States 3
(Date:4/15/2014)... Researchers at the University of California, San Diego School of ... the hepatitis C virus get liver disease and why the ... long. , The hard-to-kill pathogen, which infects an estimated ... the mitochondria dismantling the cell,s innate ability to ...
(Date:4/14/2014)... the 20th century, is currently losing a lot of ... at the University of South Carolina have just reported ... against so-called "superbugs." , Bacteria have been chipping away ... since their first wide-scale use as antibiotics in the ...
(Date:4/14/2014)... study involving serious youth offenders, the answer to one open-ended ... years: "How long do you think you,ll live?", According to ... over time., Author Dr. Alex Piquero said the study found ... them offend at very high rates and commit more serious ...
(Date:4/14/2014)... that antibiotics can contribute to obesity. Research published ... and Chemotherapy suggests that patients on long-term antibiotic ... gut microbiota. , The study, led by Didier ... who were being treated long-term with doxycycline and hydroxychloroquine ...
(Date:4/14/2014)... alone to treat children with uncomplicated acute appendicitis is a ... fewer missed school days, according to a pilot study. The ... published online April 12 in the Journal of the ... on nonoperative management of acute appendicitis in pediatric patients in ...
Breaking Medicine News(10 mins):Health News:Breaking bad mitochondria 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 2Health News:Penicillin redux: Rearming proven warriors for the 21st century 3Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Long-term antibiotic treatment for Q fever causes weight gain 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 2Health News:Antibiotics alone are a successful treatment for uncomplicated acute appendicitis in kids 3
... -- Deaths from congenital heart defects in the United States ... decline, a new study finds. Congenital heart defects are ... variety of conditions that range from mild to severe and ... congestive heart failure and high blood pressure in arteries that ...
... By Steven Reinberg HealthDay Reporter , MONDAY, ... patients on antiplatelet therapy with either warfarin or a ... new study finds. Both therapies are prescribed for ... after a heart attack or stroke. But the Plavix-aspirin ...
... poo? Working with mice and human ... Memorial Sloan-Kettering Cancer Center, New York, have generated ... bacteria in the gut could identify patients at ... bacterium vancomycin-resistant Enterococcus (VRE). Bacterial infections acquired ...
... The New York Academy of Sciences, in partnership with the ... Not to Be: The Self as Illusion" on Tuesday, December ... Evan Thompson will join cardiologist and expert on near-death experiences, ... philosophy that shed light on whether our conscious experience of ...
... -- A new Mayo Clinic study ( ... brain tumors (gliomas) ( http://www.mayoclinic.org/brain-tumors/ ) who ... tumor have an increased chance of overall ... adding radiation therapy to a less complete ...
... Alan Mozes HealthDay Reporter , MONDAY, Nov. 22 ... than double the lifetime risk for experiencing a stroke compared ... new research suggests. The finding stems from a survey ... had experienced parental divorce when they were young children or ...
Cached Medicine News:Health News:Deaths From Congenital Heart Defects on the Decline 2Health News: Bleeding Risk With Plavix-Aspirin Regimen May Be Serious 2Health News: Bleeding Risk With Plavix-Aspirin Regimen May Be Serious 3Health News:JCI table of contents: Nov. 22, 2010 2Health News:JCI table of contents: Nov. 22, 2010 3Health News:JCI table of contents: Nov. 22, 2010 4Health News:JCI table of contents: Nov. 22, 2010 5Health News:JCI table of contents: Nov. 22, 2010 6Health News:JCI table of contents: Nov. 22, 2010 7Health News:JCI table of contents: Nov. 22, 2010 8Health News:JCI table of contents: Nov. 22, 2010 9Health News:JCI table of contents: Nov. 22, 2010 10Health News:JCI table of contents: Nov. 22, 2010 11Health News:JCI table of contents: Nov. 22, 2010 12Health News:To be or not to be? Public event examines question of human identity and consciousness 2Health News:Mayo Clinic study finds aggressive surgery is best for children with brain tumors 2Health News:Children of Divorce Face Twice the Lifetime Risk of Stroke: Study 2Health News:Children of Divorce Face Twice the Lifetime Risk of Stroke: Study 3
... System gets the job done and ... with a review rate far lower ... accurate, physicians are more confident and ... 120 Hematology System, for great performance, ...
Ac.T 5diff CP allows quick and direct access to a closed sample tubea feature that reduces manual sample handling, saves time and enhances safety by eliminating operators exposure to biohazards....
Creatinine Test Kit (enzymatic), Wavelength: 340 nm. Linear range: up to 20 mg/dL....
Intended for the quantitative determination of creatinine in serum, plasma, or urine. Reaction: Endpoint. Wavelength: 340 nm. Linearity: 10 mg/dL (880 mol/L). Two vials, dry powder reagents....
Medicine Products: